Biotech Growth Trust notes ARCHIMED’s agreement to acquire portfolio company Esperion Therapeutics for up to $1.1 billion, including contingent milestone payments...
Cora Gold’s CEO explains the strategic rationale behind its US$120 million streaming agreement with Eagle Eye, the benefits over traditional project finance, and the next milestones toward construction and production..
Retail property is increasingly being driven by purposeful shoppers, making asset quality, tenant mix and trading evidence more important for investors...
Time Finance plc CEO Ed Rimmer discusses why forecasting, cash flow management and flexible funding solutions are becoming increasingly important for SMEs facing inflation, supply chain disruption and economic uncertainty...
Hardman & Co analyst Mark Thomas highlights Arbuthnot Banking Group’s improving credit metrics, growth in specialist lending and wealth management, and the potential for higher-for-longer interest rates to support stable..
JPMorgan European Discovery Trust highlighted strong contributions from Lottomatica and Alzchem in March, with the outlook supported by healthy corporate profits, fiscal stimulus and improving activity across continental Europe...
Criterium Energy has appointed Ben Arnott as a non-independent director and strategic advisor and announced details for its 2026 Annual General Meeting...
Pearson said underlying sales rose 4% in Q1 2026, supported by strong Virtual Learning growth, and confirmed it remains on track to meet full-year guidance...
Genflow Biosciences’ 2025 results highlight strong operational progress, including a major milestone in its dog aging study, advancement of its MASH program toward clinical readiness, expanded global patent protection, and..
Fidelity European Trust highlighted its long-term focus on attractively valued companies with strong cash generation and dividend growth potential, as TotalEnergies and Deutsche Boerse contributed positively in March...
Fidelity Asian Values reported an 18.1% NAV gain for the year to 31 March 2026, with share price rising 23.5%, supported by stock selection and exposure to value opportunities across..
Biotech Growth Trust notes ARCHIMED’s agreement to acquire portfolio company Esperion Therapeutics for up to $1.1 billion, including contingent milestone payments...
Cora Gold’s CEO explains the strategic rationale behind its US$120 million streaming agreement with Eagle Eye, the benefits over traditional project finance, and the next milestones toward construction and production in Mali...
Retail property is increasingly being driven by purposeful shoppers, making asset quality, tenant mix and trading evidence more important for investors...
Time Finance plc CEO Ed Rimmer discusses why forecasting, cash flow management and flexible funding solutions are becoming increasingly important for SMEs facing inflation, supply chain disruption and economic uncertainty...
Hardman & Co analyst Mark Thomas highlights Arbuthnot Banking Group’s improving credit metrics, growth in specialist lending and wealth management, and the potential for higher-for-longer interest rates to support stable profits and a near 7% yield in 2026...
JPMorgan European Discovery Trust highlighted strong contributions from Lottomatica and Alzchem in March, with the outlook supported by healthy corporate profits, fiscal stimulus and improving activity across continental Europe...
Criterium Energy has appointed Ben Arnott as a non-independent director and strategic advisor and announced details for its 2026 Annual General Meeting...
Pearson said underlying sales rose 4% in Q1 2026, supported by strong Virtual Learning growth, and confirmed it remains on track to meet full-year guidance...
Genflow Biosciences’ 2025 results highlight strong operational progress, including a major milestone in its dog aging study, advancement of its MASH program toward clinical readiness, expanded global patent protection, and new partnerships supporting future development...
Fidelity European Trust highlighted its long-term focus on attractively valued companies with strong cash generation and dividend growth potential, as TotalEnergies and Deutsche Boerse contributed positively in March...
Fidelity Asian Values reported an 18.1% NAV gain for the year to 31 March 2026, with share price rising 23.5%, supported by stock selection and exposure to value opportunities across Asian small caps...
